From GlobeNewswire:

Syntec Optics is set to enable optics for blindness by integrating their product with bioengineered artificial corneas. This development comes as a game-changer, especially with a shortage of human tissue for cornea transplants. Patients who were blind for decades regained their sight with this artificial cornea, showcasing its effectiveness in improving patient health. Syntec Optics aims to continue pushing the boundaries of innovation to help individuals suffering from vision loss. This breakthrough in optics technology highlights the company’s commitment to providing cutting-edge solutions for various healthcare challenges.

Overall, Syntec Optics Holdings, Inc. (Nasdaq: OPTX) is a key player in the optics and photonics industry, specializing in scientific, technical, aerospace, and defense instruments. With a strong focus on innovation and precision manufacturing, Syntec Optics continues to drive advancements in various sectors, such as LEO satellite optics and biomedical equipment. The company’s recent success in enabling optics for blindness further solidifies its position as a leader in the field. Through biomimicry and advanced technologies, Syntec Optics strives to enhance patient care, improve military capabilities, and deliver exceptional products to consumers worldwide.



Read more at GlobeNewswire: OPTX) Enabling Optics for Blindness